Does the price of Wegovy go up with each dose increase?

Does the cost of each Wegovy pen reflect its strength?

Generally, yes. Wegovy's dosing schedule starts at 0.25mg and steps up (through 0.5mg, 1mg, 1.7mg, 2.4mg, and now a 7.2mg maintenance dose following MHRA approval in early 2026) with each step titrated by your prescriber roughly every four weeks. Private providers price these pens individually, and stronger pens tend to carry a higher price tag. So someone who has reached the 2.4mg maintenance dose will usually be paying more per month than they were at the start of treatment. This is a question our prescribers hear most weeks, often from people who noticed the bill creeping up and weren't sure whether that was expected or whether something had gone wrong with their order.

It is worth knowing that the price increase between dose steps is not uniform across providers, and the figures reported in the press reflect list prices rather than what any one pharmacy charges. Eli Lilly raised the UK list price of Mounjaro significantly from September 2025; Wegovy pricing has its own trajectory. The history of Wegovy price changes in the UK is useful background if you want to understand how we got to current market levels. For real-time pricing across the full dose schedule, the Wegovy price overview sets out what private treatment currently looks like.

What do headline prices for each dose actually include?

This is where the comparison gets blurry. A provider showing a low per-pen price for the starter dose may not be showing the full picture. Common extras that headline figures leave out include the initial consultation fee, the cost of writing and issuing a prescription, delivery charges, and any clinical review required before a dose increase is approved. When those are added up, the apparent saving at a lower dose can shrink considerably.

At higher doses (and especially at 7.2mg, which the MHRA approved as a dedicated single-dose pen in April 2026) some providers charge separately for the clinical evidence review that most responsible pharmacies require before stepping a patient up. That review is not optional; NICE's guidance on semaglutide for weight management is clear that ongoing clinical oversight is part of appropriate use of this medicine, not an add-on. The monthly dosage guide for Wegovy explains how the titration schedule typically unfolds and what that means for planning your budget over time.

It is also worth checking whether a provider's price is fixed for a given dose or whether it changes if you need to stay at a lower dose for longer because of side effects. Gastrointestinal symptoms (nausea is the most common) sometimes mean a prescriber keeps a patient at a lower dose for an additional month. A transparent pricing model should not penalise you for doing the titration safely.

Where does nume sit on price, and why?

We are not the cheapest option in this market, and that is a deliberate choice rather than an oversight. One price covers everything: the clinical consultation, the prescription, the medicine itself, and free next-working-day delivery by DPD in plain packaging. There are no separate review fees when your prescriber assesses a dose increase, no delivery charges added at checkout, and no subscription that bills you automatically. The full treatment pricing is shown on our treatments page, the figure there is the figure you pay.

If you want to understand how the cost picture has shifted over time, projections for future Wegovy pricing and the question of whether prices have ever come down are both covered in detail. Our full Wegovy cost breakdown sits alongside those pages if you want a complete picture before deciding.

Is price the right thing to compare when choosing a provider?

For a prescription medicine, probably not, or at least not on its own. Wegovy is a Prescription-Only Medicine subject to UK regulation. The NHS medicines information for semaglutide is clear that it requires a prescriber's assessment because it carries real contraindications and a side-effect profile that needs monitoring. A provider offering significant savings without transparency about what those savings come from (fewer clinical reviews, no identity verification, no aftercare support) may be cutting corners that matter.

The MHRA has issued repeated warnings about semaglutide products sold without proper clinical oversight, and counterfeit pens have caused serious harm in the UK. Verifying that any pharmacy you use is registered with the GPhC is a basic but important check, the register is publicly searchable at pharmacyregulation.org. Our own registration number is 9012878 if you want to check us. For the cost of Wegovy's starter dose in context, or to read more about the full treatment journey, our Wegovy overview is the place to start. When you are ready to speak with a prescriber, start your free consultation and our team will review your details the same day.